Removes the provision of the Federal Food, Drug, and Cosmetic Act prohibiting the use in drug or device labeling and advertising of representations of approval under such Act.
Received in the Senate and read twice and referred to the Committee on Labor and Human Resources.
Introduced in House
Introduced in House
Referred to House Committee on Energy and Commerce.
Referred to Subcommittee on Health and the Environment.
Subcommittee Hearings Held.
Subcommittee Consideration and Mark-up Session Held.
For Further Action See H.R.3851.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line